PROTIME-FITNESS HOLISTIC HEALTH AND WELLNESS

  Taking short breaks may help our brains learn new skills Scientists discover that the resting brain repeatedly replays compressed memories of what was just practiced In a study of healthy volunteers, National Institutes of Health researchers have mapped out the brain activity that flows when we learn a new skill, such as playing a new song on the piano, and discovering why taking short breaks from practice is a key learning. The researchers found that the volunteers' brains rapidly and repeatedly replayed faster versions of the activity seen while they practiced typing a code during rest. The more a volunteer replayed the activity, the better they performed during subsequent practice sessions, suggesting rest strengthened memories. "Our results support the idea that wakeful rest plays just as important a role as practice in learning a new skill. It appears to be the period when our brains compress and consolidate memories of what we just practiced," said Leonardo G. Coh

  Protein identified as a new therapeutic anti-viral target for COVID-19 New research identified a novel interaction between the SARS-CoV-2 spike protein and the galectin-3-binding protein (LGALS3BP), which could be a new therapeutic anti-viral target. The research also found that detectable viral RNA in blood in COVID-19 patients is a strong predictor of mortality. The paper, published today in  Nature Communications , was led by a group of researchers from King's College London, Guy's and St Thomas' NHS Foundation Trust and King's British Heart Foundation Centre. The research was funded by the NIHR Guy's and St Thomas' Biomedical Research Centre and supported by grants from BHF. The authors analyzed close to 500 blood samples from patients admitted to Guy's and St. Thomas' and King's College Hospitals. The authors compared plasma and serum samples between patients admitted to intensive care units (ICU) with COVID-19 and hospitalized non-ICU COVID-1

  Cholesterol metabolite induces the production of cancer-promoting vesicles. Scientists working to understand the cellular processes linking high cholesterol to breast cancer recurrence and metastasis report that a byproduct of cholesterol metabolism causes some cells to send out cancer-promoting signals to other cells. These signals are packaged in membrane-bound compartments called extracellular vesicles. As reported in the journal  Endocrinology , the discovery could lead to new anti-cancer therapies, researchers say. "Extracellular vesicles play an important role in normal physiology, but they also have been implicated before in cancer biology," said study lead Erik Nelson, a molecular and integrative physiology professor at the University of Illinois Urbana-Champaign. "These particles carry cargo from one cell to another. This cargo is important because it's diverse and acts as a communication network. But very little is known about what regulates the vesicles.

  New research may explain why some people derive more benefits from exercise than others. Although everyone can benefit from exercise, the mechanistic links between physical fitness and overall health are not fully understood, nor are the reasons why the same exercise can affect different people. Now a study published in  Nature Metabolism  led by investigators at Beth Israel Deaconess Medical Center (BIDMC) provides insights related to these unanswered questions. The results could help determine the specific types of exercise most likely to benefit a particular individual and identify new therapeutic targets for diseases related to metabolism. " While groups as a whole benefit from exercise, the variability in responses between any two individuals undergoing the very same exercise regimen is actually quite striking. For example, some may experience improved endurance while others will see improved blood sugar levels," said senior corresponding author Robert E. Gerszten, MD,

  Amazon indigenous group's lifestyle may hold the key to slowing down aging Tsimane people are unique for their healthy brains that age more slowly A team of international researchers has found that the Tsimane indigenous people of the Bolivian Amazon experience less brain atrophy than their American and European peers. The decrease in their brain volumes with age is 70% lower than in Western populations. Accelerated brain volume loss can be a sign of dementia. The study was published May 26, 2021, in  Gerontology, Series A: Biological Sciences and Medical Sciences . Although people in industrialized nations have access to modern medical care, they are more sedentary and eat a diet high in saturated fats. In contrast, the Tsimane have little or no access to health care but are extremely physically active and consume a high-fiber diet that includes vegetables, fish, and lean meat. "The Tsimane have provided us with an amazing natural experiment on the potentially detrimental e

  The causal mechanism of link between cancer and obesity A review study led by Maria D. Sanchez-Pino, Ph.D., an assistant research professor in Interdisciplinary Oncology and Genetics at LSU Health New Orleans' School of Medicine and Stanley S. Scott Cancer Center, advances knowledge about the connection between obesity-associated inflammation and cancer. The researchers suggest that inflammatory cells with immunosuppressive properties may be critical biological links between obesity and cancer risk, progression, and metastasis. The paper is published in the June 2021 issue of  Obesity , available here. Despite evidence showing that obesity increases the risk of cancer progression, efforts are needed to identify the causal relationship between immunosuppressive cells and the response of immunotherapy in patients with obesity. The function of myeloid cells is shaped by the metabolic microenvironment. Along with macrophages, myeloid cells with immunosuppressive properties called Mye

  A preclinical study suggests a new approach to reduce COVID-19 death among the elderly. New research from the University of Minnesota Medical School and colleagues at the Mayo Clinic reveals a possible new approach to preventing death and severe disease in elderly people infected with SARS-CoV-2 . The researchers demonstrated in a preclinical study that senolytic drugs significantly reduced mortality upon infection from a beta-coronavirus closely related to SARS-CoV-2 in older mice. The study published in  Science  was co-led by Laura Niedernhofer, MD, Ph.D. and Paul Robbins, Ph.D., both professors in the Department of Biochemistry, Molecular Biology and Biophysics and co-directors of the Institute on the Biology of Aging and Metabolism at the U of M Medical School, and Sara Hamilton, Ph.D., assistant professor in the Department of Laboratory Medicine and Pathology. Senescent cells -- which are cells in the body that are damaged -- contribute to inflammation, multiple chronic disease